Posted in | News | Materials Processing | Mining

Freeman Powder Characterization Devices Gaining Popularity in the US

Having made its first direct appointment in the United States in 2007, powder characterization company Freeman Technology has seen continued growth in sales of the FT4 Powder Rheometer into this market, with the pharmaceutical sector particularly strong. Since taking up the role of Application Specialist for Freeman Technology in the US, John Yin has established a base in New York from where the company is providing a range of applications and technical support. John and other specialists from the Freeman team will be on hand at Interphex to discuss all aspects of powder characterization.

The FT4 from Freeman Technology has evolved to become a universal powder tester and is proving important in linking processing experience with powder characterization data. This extension of basic process understanding translates into better powder formulation and improved process design.

Managing director Reg Freeman is clear about the benefits of mining the often extensive experience that resides within manufacturing companies:

“The properties of powders that do or do not flow well in a process can be measured and correlated with processability experience. Using this information we can determine the optimum powder properties for a particular process line, and can predict the processability of a new formulation or begin to understand batch to batch variablility,” he said.

“Unlike traditional single number assessments of powder characteristics, the FT4 provides comprehensive information. It is this measurement of dynamic flow, shear and bulk properties that more closely reflects the complexities of powder behaviour, enabling us to make correlations and draw on real experience.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.